新的方法:准心脉鼻中的同情性外流
Dagmara Hering1, Krzysztof Narkiewicz1
1Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland.
Blood pressure
|July 20, 2023
概括
失控的高血压仍然是心血管疾病的主要原因. 基于设备的疗法,包括脏缩和巴罗反射激活,在药物失败时显示出对治疗耐药高血压的承诺.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗器械 医疗器械
背景情况:
- 失控的高血压显著导致全球心血管疾病 (CVD) 发病率和死亡率.
- 尽管有治疗方法,但只有50%的高血压患者能够充分控制血压 (BP).
- 诸如不服药和临床人员惯性等因素阻碍了高血压的有效管理,增加了心血管疾病风险和医疗负担.
研究的目的:
- 审查目前用于高血压管理的基于设备的治疗方法的现状.
- 突出神经幽默激活作为治疗点的潜力.
- 探索传统多药学之外的替代和辅助治疗选择.
主要方法:
- 审查现有的临床数据和对高血压基于设备的治疗方法的研究.
- 专注于针对神经幽默激活和巴罗反射通路的疗法.
- 包括脏剥皮 (RDN),巴罗反射激活疗法 (BAT),动脉体剥皮 (CBD) 和其他新兴设备干预措施.
主要成果:
- 在高血压管理中,RDN和BAT的确有临床经验.
- 其他基于设备的方法,如CBD和中央动脉静脉解剖,也在调查中.
- 这些疗法提供了潜在的机制来解决高血压的病理生理学.
结论:
- 基于设备的疗法代表了管理耐性高血压的日益增长的领域.
- 需要进一步的研究来确定这些设备作为药物治疗的替代品或辅助剂的最佳作用.
- 这些创新方法可能为难以控制的高血压患者提供新的希望,并降低相关的心血管疾病风险.
更多相关视频
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Neural Regulation of Blood Pressure
2.9K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.9K
Adrenergic Agonists: Direct-Acting Agents
1.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.6K
Heart Failure Drugs: β-Blockers
364
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
364
Regulation of the Cardiovascular System
1.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.2K
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481


